‡a
Author's Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial
‡a
Author's Feasibility study of a synchronized diastolic injection with low contrast volume for proper quantitative assessment of aortic regurgitation in porcine models
‡a
Author's Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study
‡a
2yearsclinicaloutcomeswiththestateoftheartpciforthetreatmentofbifurcationlesionsasubanalysisofthesyntax2study
‡A
Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study
‡9
1
‡a
impactofestablishedcardiovasculardiseaseonoutcomesintherandomizedgloballeaderstrial
‡A
Impact of established cardiovascular disease on outcomes in the randomized global leaders trial
‡9
1
‡a
feasibilitystudyofasynchronizeddiastolicinjectionwithlowcontrastvolumeforproperquantitativeassessmentofaorticregurgitationinporcinemodels
‡A
Feasibility study of a synchronized diastolic injection with low contrast volume for proper quantitative assessment of aortic regurgitation in porcine models
‡9
1
‡a
clinicalrelevanceofticagrelormonotherapyfollowing1monthdualantiplatelettherapyafterbifurcationpercutaneouscoronaryinterventioninsightfromgloballeaderstrial
‡A
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial
‡9
1
‡a
impactofpostproceduralminimalstentareaon2yearclinicaloutcomesinthesyntax2trial
‡A
Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial
‡9
1
